Miguel González Vélez

Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer

Miguel González Vélez, Heidi Kosiorek, Jan B. Egan et al. · Prostate Cancer and Prostatic Diseases · 2021 · 69 citations · Full text

Medicine, Oncology, Urology +17

Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials

Narjust Duma, Sejal Kothadia, Tariq U. Azam et al. · The Oncologist · 2018 · 65 citations · Full text

Medicine, Oncology, Chemotherapy +5

Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer

Laura A. Sena, Julia Fountain, Pedro Isaacsson Velho et al. · The Oncologist · 2020 · 58 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Epidemiological trends of oropharyngeal and oral cavity squamous cell carcinomas in Northern New England, 2000–2013

Adepitan A. Owosho, Miguel González Vélez, Alexander Tyburski et al. · Cancer Causes & Control · 2019 · 16 citations

Medicine, Oncology, Oral Oncology +10